UNSPSC 51363101: Alonimid

This classification denotes a sedative and hypnotic with the molecular formula C14H13NO3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 14144823D4, chemically known as 1,2,3,4-tetrahydronaphthalin-1-spiro-3-piperidin-4,2,6-dion but generally known as alonimid, which bears US NIH Compound Identifier 17928. European Medicines Agency schedules Alonimid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05356MIG.

UNSPSC 51363101 Alonimid (Commodity) covers pharmaceutical products state and local governments procure to support public health and community safety initiatives, specifically naloxone and drug deactivation systems for overdose response and controlled substance management. The code reflects purchasing by county health departments and community health organizations seeking to stock emergency medical supplies and harm-reduction equipment for distribution or emergency deployment, with vendors responsible for delivery logistics and compliance with federal workplace and employment verification standards.

Seminole County, Florida issued an IFB (IFB60459723LAS) posted June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford. The contract carries a two-year initial term with a one-year renewal option, includes a three-month probationary termination clause, and requires bidders to comply with E-Verify, drug-free workplace certification, and federal environmental and compliance standards. The source shows limited recent state and local activity under this specific code; this single opportunity does not establish a broader geographic or issuing-body pattern sufficient to characterize market concentration or future procurement trends.